19 June 2013
Keywords: novartis, unveils, european, data, zelmac, announced, results
Article | 16 November 1999
Novartis has announced the results of its European study of Zelmac(tegaserod) in patients with irritable bowel syndrome, complementing the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.